Serial Number
87824693
Owner
JUBILANT DRAXIMAGE INC.Attorney
Lisa M. MelansonFirst Use Date
Jun 30, 2018
Filing Date
Mar 7, 2018
Serial #87824693 Trademark
Serial Number: 87824693 • Registration: 6278307
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 16 - Paper Goods
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Owner Contact Info
Legal Representation
Correspondence Address
Lisa M. Melanson McCarthy Tétrault LLP
745 Thurlow Street
c/o Suite 2400
Vancouver, BC, V6E0C5
CANADA
Trademark Details
Filing Date
March 7, 2018
Registration Date
February 23, 2021
First Use Anywhere
June 30, 2018
First Use in Commerce
June 30, 2018
Published for Opposition
April 2, 2019
Goods & Services
Providing online newsletters relating to an educational program in the field of thyroid cancer; Educational services, namely, conducting classes, seminars, conferences and workshops intended to healthcare professionals and general public, who have been diagnosed with thyroid cancer, explaining the disease, diagnoses, treatments and follow up; educational services, namely, providing non- downloadable webinars intended to healthcare professionals and general public, who have been diagnosed with thyroid cancer, explaining the disease, diagnoses, treatments and follow up; Providing a website featuring information relating to educational services intended to healthcare professionals and general public, who have been diagnosed with thyroid cancer, explaining the disease, diagnoses, treatments and follow up; Providing online non-downloadable newsletters and websites featuring information relating to an educational program in the field of thyroid cancer
Printed newsletters, informational flyers and brochures relating to an educational program in the field of thyroid cancer
Online downloadable newsletters and digital advertising, namely, downloadable informational flyers relating to an educational program in the field of thyroid cancer; downloadable webinars intended to healthcare professionals and general public, who have been diagnosed with thyroid cancer, explaining the disease, diagnoses, treatments and follow up
